tiprankstipranks
Trending News
More News >
China Regenerative Medicine International Limited (HK:8158)
:8158
Hong Kong Market

China Regenerative Medicine International Limited (8158) Ratios

Compare
0 Followers

China Regenerative Medicine International Limited Ratios

HK:8158's free cash flow for Q2 2025 was HK$0.65. For the 2025 fiscal year, HK:8158's free cash flow was decreased by HK$ and operating cash flow was HK$-0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.89 1.14 1.57 1.75 0.71
Quick Ratio
0.88 1.14 1.57 1.75 0.71
Cash Ratio
0.12 0.02 0.01 0.07 0.02
Solvency Ratio
0.05 -0.55 0.06 0.35 -1.39
Operating Cash Flow Ratio
0.05 0.04 -0.11 -0.02 -1.98
Short-Term Operating Cash Flow Coverage
0.82 0.47 -0.36 -0.10 -19.60
Net Current Asset Value
HK$ -75.74MHK$ -5.53MHK$ 77.10MHK$ 110.97MHK$ -64.03M
Leverage Ratios
Debt-to-Assets Ratio
0.48 0.27 0.26 0.14 0.28
Debt-to-Equity Ratio
2.62 4.26 0.69 0.32 0.74
Debt-to-Capital Ratio
0.72 0.81 0.41 0.24 0.43
Long-Term Debt-to-Capital Ratio
0.62 0.65 0.00 0.00 0.00
Financial Leverage Ratio
5.43 15.76 2.66 2.32 2.62
Debt Service Coverage Ratio
-3.67 -6.53 0.22 1.70 -3.47
Interest Coverage Ratio
0.00 -111.46 11.04 87.75 -6.92
Debt to Market Cap
0.31 0.22 0.15 0.04 0.02
Interest Debt Per Share
0.25 0.18 0.26 0.13 0.38
Net Debt to EBITDA
-5.17 -0.49 4.86 0.40 -0.31
Profitability Margins
Gross Profit Margin
61.91%27.95%16.24%23.94%24.29%
EBIT Margin
-24.59%-153.58%3.91%22.99%-66.68%
EBITDA Margin
-22.86%-137.30%6.23%22.86%-66.07%
Operating Profit Margin
-24.59%-157.04%3.72%22.83%-69.14%
Pretax Profit Margin
9.50%-154.99%3.57%22.73%-149.63%
Net Profit Margin
9.50%-154.99%1.97%18.32%-156.31%
Continuous Operations Profit Margin
9.50%-154.99%1.97%18.32%-83.35%
Net Income Per EBT
100.00%100.00%55.10%80.61%104.46%
EBT Per EBIT
-38.64%98.70%95.90%99.54%216.42%
Return on Assets (ROA)
3.50%-57.93%1.65%20.00%-189.98%
Return on Equity (ROE)
20.39%-913.25%4.38%46.39%-498.40%
Return on Capital Employed (ROCE)
-14.59%-286.35%7.32%57.75%263.64%
Return on Invested Capital (ROIC)
-13.04%-175.63%2.70%35.26%1186.42%
Return on Tangible Assets
3.50%-57.93%1.65%20.00%-189.98%
Earnings Yield
3.30%-68.37%1.44%6.48%-31.63%
Efficiency Ratios
Receivables Turnover
61.81 58.10 3.26K 0.00 2.32K
Payables Turnover
13.34 20.24 3.66K 2.42K 17.55
Inventory Turnover
75.18 112.50 678.28 560.34 101.83
Fixed Asset Turnover
2.10 4.01 8.64 375.69 142.13
Asset Turnover
0.37 0.37 0.84 1.09 1.22
Working Capital Turnover Ratio
-8.74 1.24 2.29 10.56 -25.19
Cash Conversion Cycle
-16.59 -8.50 0.55 0.50 -17.06
Days of Sales Outstanding
5.91 6.28 0.11 0.00 0.16
Days of Inventory Outstanding
4.86 3.24 0.54 0.65 3.58
Days of Payables Outstanding
27.35 18.03 0.10 0.15 20.80
Operating Cycle
10.76 9.53 0.65 0.65 3.74
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 0.02 -0.06 -0.01 -2.48
Free Cash Flow Per Share
<0.01 0.02 -0.07 -0.01 -2.48
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
0.79 0.96 1.15 1.27 1.00
Dividend Paid and CapEx Coverage Ratio
4.76 23.13 -6.81 -3.74 0.00
Capital Expenditure Coverage Ratio
4.76 23.13 -6.81 -3.74 0.00
Operating Cash Flow Coverage Ratio
0.04 0.13 -0.25 -0.08 -9.21
Operating Cash Flow to Sales Ratio
0.05 0.09 -0.08 -0.01 -2.15
Free Cash Flow Yield
1.41%3.85%-6.39%-0.48%-43.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
30.34 -1.46 69.56 15.42 -3.16
Price-to-Sales (P/S) Ratio
2.87 2.27 1.37 2.83 4.94
Price-to-Book (P/B) Ratio
5.78 13.36 3.05 7.15 15.76
Price-to-Free Cash Flow (P/FCF) Ratio
71.06 25.98 -15.65 -208.61 -2.30
Price-to-Operating Cash Flow Ratio
56.30 24.85 -17.95 -264.46 -2.30
Price-to-Earnings Growth (PEG) Ratio
-0.58 <0.01 -0.76 -0.14 0.05
Price-to-Fair Value
5.78 13.36 3.05 7.15 15.76
Enterprise Value Multiple
-17.74 -2.14 26.80 12.76 -7.79
Enterprise Value
236.10M 204.38M 386.99M 825.10M 954.29M
EV to EBITDA
-17.74 -2.14 26.80 12.76 -7.79
EV to Sales
4.06 2.94 1.67 2.92 5.15
EV to Free Cash Flow
100.26 33.70 -19.12 -215.37 -2.40
EV to Operating Cash Flow
79.18 32.25 -21.92 -273.03 -2.40
Tangible Book Value Per Share
0.10 0.04 0.36 0.39 -0.34
Shareholders’ Equity Per Share
0.10 0.04 0.36 0.39 0.36
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.45 0.19 -0.04
Revenue Per Share
0.19 0.24 0.81 0.99 1.15
Net Income Per Share
0.02 -0.38 0.02 0.18 -1.80
Tax Burden
1.00 1.00 0.55 0.81 1.04
Interest Burden
-0.39 1.01 0.91 0.99 2.24
Research & Development to Revenue
0.00 0.00 0.00 0.00 <0.01
SG&A to Revenue
0.71 0.56 0.10 0.15 0.86
Stock-Based Compensation to Revenue
0.00 0.00 0.00 <0.01 0.01
Income Quality
0.54 -0.06 -2.14 -0.12 0.94
Currency in HKD